维普中文期刊产品整合服务
76篇 您的检索式:作者名="Symanowski"
    题名 作者 年代 出处 被引量
1Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural masothelioma 显示文摘Vogelzang NJ Rusthoven J J Symanowski J 2003J Clin Oncol2003,21,14:1
2Circulating tumor cells in patients with castration- resistant prostate cancer baseline values and correlation with prognostic factors 显示文摘Goodman OB Jr Fink LM Symanowski JT 2009Cancer Epidemiol Biomarkers Prey2009,18,6:1
3Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin along in patients with malignant pleural mesothelioma 显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,14:1
4PhaseⅢstudy of pemetrexed in combination with cisplatin versus cisplatin alone in patients with magligant pleural mesothelioma显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 0,,:1
5Phase Ⅲ study of pemetrexd in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘 Rusthoven J Symanowski J 2003J Clin Oncol2003,21,14:1
6Phase Ⅲ study of Pemetrexed in combination with Cisplatin versus Cisplatin alone in patients with malignant pleural mesothelioma 显示文摘Vogelzang N J Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,14:1
7Phase Ill study of pemetrexed in combinatfon with cisplatin versus cfsplatfn alone in patients with malignant pleural mesothelioma 显示文摘Vogelzang NJ P usthoven JJ Symanowski J 2005J Clin Onco2005,21,54:1
8Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in pa- tients with malignant pleural mesothelioma 显示文摘Vogelzang N J Rusthoven JJ Symanowski J 2003Clin Oncol2003,21,14:1
9Clin Genitourin Cancer显示文摘Goodman OB Jr Symanowski JT Loudyi A Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer 20119( 1 ) :31-382011,9,1:1
10Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignantpleural mesothelioma显示文摘Vogelzang N J Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,:1
11Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,:1
12Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘VOGELZANG N J RUSTHOVEN J J SYMANOWSKI J 2003J Clin Oncol2003,21,14:1
13Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,14:1
14Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma 显示文摘Vogelzang N J Rusthoven JJ Symanowski J 2003Clin Oncol2003,21,14:1
15Phasestudy of pemetrexed in combination with cisplatin versuscisplatin alone in patients with malignant pleural mesothe-lioma显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,14:1
16Circulating tumor cells in patients with castration-resistant prostate cancer baseline values and correlation with prognostic factors显示文摘Goodman OB Jr Fink LM Symanowski JT 2009Cancer Epidemiol Biomarkers Prev2009,18,6:1
17Phase Ⅲ study of peme trexed incombination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,14:1
18A phase ii clin-ical trial of oral valproic acid in patients with castration-resistantprostate cancers using an intensive biomarker sampling strategy显示文摘SHARMA S SYMANOWSKI J WONG B 2008Transl 0nco/2008,1,3:1
19Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,14:1
20Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cispla- tin Alone in Patients With Malignant Pleural Mesothelioma 显示文摘Vogelzang N J Rusthoven J J Symanowski J 2003Journal of Clinical Oneology2003,21,14:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费